"Triglycerides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D014280
|
| MeSH Number(s) |
D10.351.801
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Triglycerides".
Below are MeSH descriptors whose meaning is more specific than "Triglycerides".
This graph shows the total number of publications written about "Triglycerides" by people in this website by year, and whether "Triglycerides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 4 | 6 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 2 | 2 | 4 |
| 2000 | 1 | 2 | 3 |
| 2001 | 5 | 11 | 16 |
| 2002 | 3 | 5 | 8 |
| 2003 | 4 | 13 | 17 |
| 2004 | 3 | 12 | 15 |
| 2005 | 5 | 7 | 12 |
| 2006 | 4 | 13 | 17 |
| 2007 | 3 | 6 | 9 |
| 2008 | 9 | 8 | 17 |
| 2009 | 7 | 11 | 18 |
| 2010 | 3 | 13 | 16 |
| 2011 | 6 | 14 | 20 |
| 2012 | 6 | 20 | 26 |
| 2013 | 10 | 17 | 27 |
| 2014 | 9 | 18 | 27 |
| 2015 | 5 | 10 | 15 |
| 2016 | 7 | 9 | 16 |
| 2017 | 5 | 11 | 16 |
| 2018 | 5 | 2 | 7 |
| 2019 | 8 | 14 | 22 |
| 2020 | 1 | 14 | 15 |
| 2021 | 5 | 6 | 11 |
| 2022 | 0 | 12 | 12 |
| 2023 | 0 | 6 | 6 |
| 2024 | 7 | 7 | 14 |
| 2025 | 1 | 9 | 10 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Triglycerides" by people in Profiles.
-
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial. Nat Med. 2026 Apr; 32(4):1432-1443.
-
C-reactive protein-triglyceride-glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome. J Clin Lipidol. 2026 05; 20(5):915-925.
-
Screening, Diagnosis, and Management of Pediatric Hypertriglyceridemia: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2026 Apr; 46(4):e000195.
-
Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies. Curr Cardiol Rep. 2026 Jan 03; 28(1):8.
-
Genome-wide gene-sleep interaction study identifies novel lipid loci in 732,564 participants. Atherosclerosis. 2026 Jan; 412:120603.
-
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications. Eur Heart J. 2025 Nov 21; 46(44):4737-4750.
-
Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
-
Trends in blood-based metabolic and cardiovascular risk profiles in men during treatment for testosterone deficiency: a longitudinal, retrospective cohort study. J Sex Med. 2025 09 04; 22(9):1564-1571.
-
Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors. Am J Cardiovasc Drugs. 2025 Nov; 25(6):749-766.
-
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis. EBioMedicine. 2025 Aug; 118:105840.